Drugs used to cause dilation of the blood vessels.
An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins.
The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE.
A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.
The force that opposes the flow of BLOOD through a vascular bed. It is equal to the difference in BLOOD PRESSURE across the vascular bed divided by the CARDIAC OUTPUT.
A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP.
The flow of BLOOD through or around an organ or region of the body.
A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
Part of the arm in humans and primates extending from the ELBOW to the WRIST.
Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components.
A direct-acting vasodilator that is used as an antihypertensive agent.
A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter.
The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE.
The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.
PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.
A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension.
A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
Calcitonin gene-related peptide. A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.
Drugs used to cause constriction of the blood vessels.
Arteries which arise from the abdominal aorta and distribute to most of the intestines.
The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).
The circulation of blood through the CORONARY VESSELS of the HEART.
The circulation of the BLOOD through the LUNGS.
A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
The veins and arteries of the HEART.
The neural systems which act on VASCULAR SMOOTH MUSCLE to control blood vessel diameter. The major neural control is through the sympathetic nervous system.
The circulation of blood through the BLOOD VESSELS supplying the abdominal VISCERA.
A competitive inhibitor of nitric oxide synthetase.
An NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE.
The relationship between the dose of an administered drug and the response of the organism to the drug.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
An essential amino acid that is physiologically active in the L-form.
The smallest divisions of the arteries located between the muscular arteries and the capillaries.
Paracrine substances produced by the VASCULAR ENDOTHELIUM with VASCULAR SMOOTH MUSCLE relaxation (VASODILATION) activities. Several factors have been identified, including NITRIC OXIDE and PROSTACYCLIN.
Recording of change in the size of a part as modified by the circulation in it.
The nonstriated involuntary muscle tissue of blood vessels.
A 52-amino acid peptide with multi-functions. It was originally isolated from PHEOCHROMOCYTOMA and ADRENAL MEDULLA but is widely distributed throughout the body including lung and kidney tissues. Besides controlling fluid-electrolyte homeostasis, adrenomedullin is a potent vasodilator and can inhibit pituitary ACTH secretion.
The circulation of the BLOOD through the vessels of the KIDNEY.
A potassium-channel opening vasodilator that has been investigated in the management of hypertension. It has also been tried in patients with asthma. (Martindale, The Extra Pharmacopoeia, 30th ed, p352)
A non-steroidal anti-inflammatory agent (NSAID) that inhibits the enzyme cyclooxygenase necessary for the formation of prostaglandins and other autacoids. It also inhibits the motility of polymorphonuclear leukocytes.
An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6)
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs.
A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action.
The vessels carrying blood away from the heart.
Endogenously-synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS.
The circulation of the BLOOD through the MICROVASCULAR NETWORK.
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes.
The number of times the HEART VENTRICLES contract per unit of time, usually per minute.
Compounds with a core of fused benzo-pyran rings.
A stable prostaglandin endoperoxide analog which serves as a thromboxane mimetic. Its actions include mimicking the hydro-osmotic effect of VASOPRESSIN and activation of TYPE C PHOSPHOLIPASES. (From J Pharmacol Exp Ther 1983;224(1): 108-117; Biochem J 1984;222(1):103-110)

Relaxin is a potent renal vasodilator in conscious rats. (1/7071)

The kidneys and other nonreproductive organs vasodilate during early gestation; however, the "pregnancy hormones" responsible for the profound vasodilation of the renal circulation during pregnancy are unknown. We hypothesized that the ovarian hormone relaxin (RLX) contributes. Therefore, we tested whether the administration of RLX elicits renal vasodilation and hyperfiltration in conscious adult, intact female rats. After several days of treatment with either purified porcine RLX or recombinant human RLX 2 (rhRLX), effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) increased by 20%-40%. Comparable renal vasodilation and hyperfiltration was also observed in ovariectomized rats, suggesting that estrogen and progesterone are unnecessary for the renal response to rhRLX. The nitric oxide synthase inhibitor Nomega-nitro-L-arginine methyl ester completely abrogated the increase in ERPF and GFR elicited by chronic administration of purified porcine RLX. In contrast, the renal vasoconstrictory response to angiotensin II was attenuated by the RLX treatment. Short-term infusion of purified porcine RLX to conscious rats over several hours failed to increase ERPF and GFR. Plasma osmolality was consistently reduced by the chronic administration of both RLX preparations. In conclusion, the renal and osmoregulatory effects of chronic RLX administration to conscious rats resemble the physiological changes of pregnancy in several respects: (a) marked increases in ERPF and GFR with a mediatory role for nitric oxide; (b) attenuation of the renal circulatory response to angiotensin II; and (c) reduction in plasma osmolality.  (+info)

Loss of endothelium and receptor-mediated dilation in pial arterioles of rats fed a short-term high salt diet. (2/7071)

A high salt diet often is regarded as an accessory risk factor in hypertension, coincidental to the deleterious effect of high blood pressure on vasodilator function. The aim of this study was to determine whether short-term ingestion of a high salt diet per se impairs vasodilator function in the cerebral circulation independent of blood pressure changes. Adult Sprague-Dawley rats were fed a normal salt (0.8%) or high salt (4%) diet for 3 days. Mean arterial pressures were similar in the normal and high salt groups (123+/-2 and 125+/-2 mm Hg, respectively). Subsequently, the responses of the in situ pial arterioles to acetylcholine, iloprost, and sodium nitroprusside were determined in cranial windows using intravital videomicroscopy. Pial arterioles of rats fed normal and high salt diets showed similar resting diameters of 69+/-2 and 72+/-3 microm, respectively, but their reactivity patterns to vasodilator stimuli were markedly different. Arterioles of rats fed a normal salt diet dilated progressively up to 17+/-3% in response to the endothelium-dependent agent acetylcholine (10(-9) to 10(-6) mol/L) and dilated by 22+/-2% in response to the prostaglandin I2 receptor agonist iloprost (3x10(-11) mol/L). In contrast, pial arterioles of rats fed a high salt diet constricted by 4+/-3% and 8+/-2% in response to acetylcholine and iloprost, respectively. Sodium nitroprusside (10(-6) mol/L), a nitric oxide donor, dilated pial arterioles of rats fed low and high salt diets by a similar amount (19+/-3% and 16+/-2%, respectively), suggesting that signaling mechanisms for dilation distal to the vascular smooth muscle membrane were intact after high salt intake. These results provide the first evidence that the short-term ingestion of a high salt diet may severely impair the vasodilator function of the in situ cerebral microcirculation independent of blood pressure elevation.  (+info)

Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. (3/7071)

We previously reported that adrenomedullin (AM), a potent vasodilator peptide discovered in pheochromocytoma cells, stimulates nitric oxide (NO) release in the rat kidney. To further investigate whether the NO-cGMP pathway is involved in the mechanisms of AM-induced vasodilation, we examined the effects of E-4021, a cGMP-specific phosphodiesterase inhibitor, on AM-induced vasorelaxation in aortic rings and perfused kidneys isolated from Wistar rats. We also measured NO release from the kidneys using a chemiluminescence assay. AM (10(-10) to 10(-7) mol/L) relaxed the aorta precontracted with phenylephrine in a dose-dependent manner. Denudation of endothelium (E) attenuated the vasodilatory action of AM (10(-7) mol/L AM: intact (E+) -25.7+/-5.2% versus denuded (E-) -7. 8+/-0.6%, P<0.05). On the other hand, pretreatment with 10(-8) mol/L E-4021 augmented AM-induced vasorelaxation in the intact aorta (-49. 0+/-7.9%, P<0.05) but not in the denuded one. E-4021 also enhanced acetylcholine (ACh)-induced vasorelaxation in the rat intact aorta (10(-7) mol/L ACh -36.6+/-8.4% versus 10(-8) mol/L E-4021+10(-7) mol/L ACh -62.7+/-3.1%, P<0.05). In perfused kidneys, AM-induced vasorelaxation was also augmented by preincubation with E-4021 (10(-9) mol/L AM -15.4+/-0.6% versus 10(-8) mol/L E-4021+10(-9) mol/L AM -23.6+/-1.2%, P<0.01). AM significantly increased NO release from rat kidneys (DeltaNO: +11.3+/-0.8 fmol. min-1. g-1 kidney at 10(-9) mol/L AM), which was not affected by E-4021. E-4021 enhanced ACh-induced vasorelaxation (10(-9) mol/L ACh -9.7+/-1.7% versus 10(-8) mol/L E-4021+10(-9) mol/L ACh -18.8+/-2.9%, P<0.01) but did not affect ACh-induced NO release from the kidneys. In the aorta and the kidney, 10(-4) mol/L of NG-nitro-L-arginine methyl ester, an NO synthase inhibitor, and 10(-5) mol/L of methylene blue, a guanylate cyclase inhibitor, reduced the vasodilatory effect of AM. These results suggest that the NO-cGMP pathway is involved in the mechanism of AM-induced vasorelaxation, at least in the rat aorta and kidney.  (+info)

Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. (4/7071)

BACKGROUND: The cardiovascular complications of Marfan syndrome arise due to alterations in the structural and functional properties of fibrillin, a constituent of vascular connective tissues. Fibrillin-containing microfibrils are closely associated with arterial endothelial cells, indicating a possible functional role for fibrillin in the endothelium. Plasma concentrations of endothelial cell products are elevated in Marfan subjects, which indirectly indicates endothelial dysfunction. This study directly assessed flow- and agonist-mediated endothelium-dependent brachial artery reactivity in Marfan subjects. METHODS AND RESULTS: In 20 Marfan and 20 control subjects, brachial artery diameter, blood flow, and blood pressure were measured by ultrasonic wall tracking, Doppler ultrasound, and photoplethysmography, respectively. Measurements were taken during hand hyperemia (a stimulus for endothelium-derived nitric oxide [NO] release in the upstream brachial artery) and after sublingual administration of the endothelium-independent vasodilator nitroglycerin. In 9 Marfan and 6 control subjects, the above parameters were also assessed during intra-arterial infusions of acetylcholine and bradykinin (agonists that stimulate NO production) and NG-monomethyl-L-arginine (L-NMMA, an inhibitor of NO production). Flow-mediated responses differed markedly between Marfan and control subjects (-1.6+/-3.5% versus 6. 50+/-4.1%, respectively; P<0.0001), whereas nitroglycerin produced similar vasodilation (14.2+/-5.7% versus 15.2+/-7.8%; P=NS). Agonist-induced vasodilation to incremental intra-arterial infusions of acetylcholine and bradykinin were not significantly different between Marfan and control subjects, and intra-arterial L-NMMA produced similar reductions in brachial artery diameter in both groups. CONCLUSIONS: These data demonstrate impaired flow-mediated but preserved agonist-mediated endothelium-dependent vasodilation in Marfan subjects and suggest preservation of basal NO release. Selective loss of flow-mediated dilation suggests a role for fibrillin in endothelial cell mechanotransduction.  (+info)

Simultaneous assessment of effects of coronary vasodilators on the coronary blood flow and the myocardial contractility by using the blood-perfused canine papillary muscle. (5/7071)

Effects of 6 coronary vasodilators on the coronary blood flow and the contractile force of the ventricular muscle were examined simultaneously by injecting these drugs to the arterially blood-perfused canine papillary muscle preparation. All compounds produced a dose-dependent increase in blood flow rate, and relative potencies determined on the basis of doses producing a 100% increase in blood flow rate, ED100, were in the descending order : nifedipine greater than verapamil greater than diltiazem greater than dilazep greater than dipyridamole greater than carbochromen, and approximately 1 : 1/12 : 1/26 : 1/100 : 1/300 : 1/500. All drugs except for dipyridamole caused a dose-dependent decrease in the developed tension of the papillary muscle, although nifedipine and diltiazem in low doses produced a slight increase. Relative potencies determined on the basis of doses producing a 50% decrease in developed tension, ID50, were as follows: nifedipine (1), verapamil (1/13), diltiazem (1/40), dilazep (1/100), and carbochromen (1/270). Ratios of the ID50 to ED100 were as follows: diltiazem (5.2), nifedipine (3.5), verapamil (3.5), dilazep (2.5), and carbochromen (1.8). The higher the value the more predominant on the coronary vascular bed or the less depressant on the myocardial contractility were their actions.  (+info)

Inhibition of endothelium-dependent hyperpolarization by endothelial prostanoids in guinea-pig coronary artery. (6/7071)

1. In smooth muscle of the circumflex coronary artery of guinea-pig, acetylcholine (ACh, 10(-6) M) produced an endothelium-dependent hyperpolarization consisting of two components. An initial component that occurs in the presence of ACh and a slow component that developed after ACh had been withdrawn. Each component of the hyperpolarization was accompanied by an increase in membrane conductance. 2. Indomethacin (5 x 10(-6) M) or diclofenac (10(-6) M), both inhibitors of cyclooxygenase, abolished only the slow hyperpolarization. The initial hyperpolarization was not inhibited by diclofenac nor by nitroarginine, an inhibitor of nitric oxide synthase. 3. Both components of the ACh-induced hyperpolarization were abolished in the presence of atropine (10(-6) M) or high-K solution ([K+]0 = 29.4 mM). 4. The interval between ACh-stimulation required to generate an initial hyperpolarization of reproducible amplitude was 20 min or greater, but it was reduced to less than 5 min after inhibiting cyclooxygenase activity. Conditioning stimulation of the artery with substance P (10(-7) M) also caused a long duration (about 20 min) inhibition of the ACh-response. 5. The amplitude of the hyperpolarization generated by Y-26763, a K+-channel opener, was reproducible within 10 min after withdrawal of ACh. 6. Exogenously applied prostacyclin (PGI2) hyperpolarized the membrane and reduced membrane resistance in concentrations over 2.8 x 10(-9)M. 7. At concentrations below threshold for hyperpolarization and when no alteration of membrane resistance occurred, PGI2 inhibited the initial component of the ACh-induced hyperpolarization. 8. It is concluded that endothelial prostanoids, possibly PGI2, have an inhibitory action on the release of endothelium-derived hyperpolarizing factor.  (+info)

Acetylcholine-induced membrane potential changes in endothelial cells of rabbit aortic valve. (7/7071)

1. Using a microelectrode technique, acetylcholine (ACh)-induced membrane potential changes were characterized using various types of inhibitors of K+ and Cl- channels in rabbit aortic valve endothelial cells (RAVEC). 2. ACh produced transient then sustained membrane hyperpolarizations. Withdrawal of ACh evoked a transient depolarization. 3. High K+ blocked and low K+ potentiated the two ACh-induced hyperpolarizations. Charybdotoxin (ChTX) attenuated the ACh-induced transient and sustained hyperpolarizations; apamin inhibited only the sustained hyperpolarization. In the combined presence of ChTX and apamin, ACh produced a depolarization. 4. In Ca2+-free solution or in the presence of Co2+ or Ni2+, ACh produced a transient hyperpolarization followed by a depolarization. In BAPTA-AM-treated cells, ACh produced only a depolarization. 5. A low concentration of A23187 attenuated the ACh-induced transient, but not the sustained, hyperpolarization. In the presence of cyclopiazonic acid, the hyperpolarization induced by ACh was maintained after ACh removal; this maintained hyperpolarization was blocked by Co2+. 6. Both NPPB and hypertonic solution inhibited the membrane depolarization seen after ACh washout. Bumetanide also attenuated this depolarization. 7. It is concluded that in RAVEC, ACh produces a two-component hyperpolarization followed by a depolarization. It is suggested that ACh-induced Ca2+ release from the storage sites causes a transient hyperpolarization due to activation of ChTX-sensitive K+ channels and that ACh-activated Ca2+ influx causes a sustained hyperpolarization by activating both ChTX- and apamin-sensitive K+ channels. Both volume-sensitive Cl- channels and the Na+-K+-Cl- cotransporter probably contribute to the ACh-induced depolarization.  (+info)

Enantioselective inhibition of the biotransformation and pharmacological actions of isoidide dinitrate by diphenyleneiodonium sulphate. (8/7071)

1. We have shown previously that the D- and L- enantiomers of isoidide dinitrate (D-IIDN and L-IIDN) exhibit a potency difference for relaxation and cyclic GMP accumulation in isolated rat aorta and that this is related to preferential biotransformation of the more potent enantiomer (D-IIDN). The objective of the current study was to examine the effect of the flavoprotein inhibitor, diphenyleneiodonium sulphate (DPI), on the enantioselectivity of IIDN action. 2. In isolated rat aortic strip preparations, exposure to 0.3 microM DPI resulted in a 3.6 fold increase in the EC50 value for D-IIDN-induced relaxation, but had no effect on L-IIDN-induced relaxation. 3. Incubation of aortic strips with 2 microM D- or L-IIDN for 5 min resulted in significantly more D-isoidide mononitrate formed (5.0 +/- 1.5 pmol mg protein(-1)) than L-isoidide mononitrate (2.1 +/- 0.7 pmol mg protein(-1)) and this difference was abolished by pretreatment of tissues with 0.3 microM DPI. DPI had no effect on glutathione S-transferase (GST) activity or GSH-dependent biotransformation of D- or L-IIDN in the 105,000 x g supernatant fraction of rat aorta. 4. Consistent with both the relaxation and biotransformation data, treatment of tissues with 0.3 microM DPI significantly inhibited D-IIDN-induced cyclic GMP accumulation, but had no effect on L-IIDN-induced cyclic GMP accumulation. 5. In the intact animal, 2 mg kg(-1) DPI significantly inhibited the pharmacokinetic and haemodynamic properties of D-IIDN, but had no effect L-IIDN. 6. These data suggest that the basis for the potency difference for relaxation by the two enantiomers is preferential biotransformation of D-IIDN to NO, by an enzyme that is inhibited by DPI. Given that DPI binds to and inhibits NADPH-cytochrome P450 reductase, the data are consistent with a role for the cytochromes P450-NADPH-cytochrome P450 reductase system in this enantioselective biotransformation process.  (+info)

Vasodilator agents are pharmacological substances that cause the relaxation or widening of blood vessels by relaxing the smooth muscle in the vessel walls. This results in an increase in the diameter of the blood vessels, which decreases vascular resistance and ultimately reduces blood pressure. Vasodilators can be further classified based on their site of action:

1. Systemic vasodilators: These agents cause a generalized relaxation of the smooth muscle in the walls of both arteries and veins, resulting in a decrease in peripheral vascular resistance and preload (the volume of blood returning to the heart). Examples include nitroglycerin, hydralazine, and calcium channel blockers.
2. Arterial vasodilators: These agents primarily affect the smooth muscle in arterial vessel walls, leading to a reduction in afterload (the pressure against which the heart pumps blood). Examples include angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and direct vasodilators like sodium nitroprusside.
3. Venous vasodilators: These agents primarily affect the smooth muscle in venous vessel walls, increasing venous capacitance and reducing preload. Examples include nitroglycerin and other organic nitrates.

Vasodilator agents are used to treat various cardiovascular conditions such as hypertension, heart failure, angina, and pulmonary arterial hypertension. It is essential to monitor their use carefully, as excessive vasodilation can lead to orthostatic hypotension, reflex tachycardia, or fluid retention.

Papaverine is defined as a smooth muscle relaxant and a non-narcotic alkaloid derived from the opium poppy. It works by blocking the phosphodiesterase enzyme, leading to an increase in cyclic adenosine monophosphate (cAMP) levels within the cells, which in turn results in muscle relaxation.

It is used medically for its vasodilatory effects to treat conditions such as cerebral or peripheral vascular spasms and occlusive diseases, Raynaud's phenomenon, and priapism. Papaverine can also be used as an anti-arrhythmic agent in the management of certain types of cardiac arrhythmias.

It is important to note that papaverine has a narrow therapeutic index, and its use should be closely monitored due to the potential for adverse effects such as hypotension, reflex tachycardia, and gastrointestinal disturbances.

nitroprusside (ni-troe-rus-ide)

A rapid-acting vasodilator used in the management of severe hypertension, acute heart failure, and to reduce afterload in patients undergoing cardiac surgery. It is a potent arterial and venous dilator that decreases preload and afterload, thereby reducing myocardial oxygen demand. Nitroprusside is metabolized to cyanide, which must be monitored closely during therapy to prevent toxicity.

Pharmacologic class: Peripheral vasodilators

Therapeutic class: Antihypertensives, Vasodilators

Medical Categories: Cardiovascular Drugs, Hypertension Agents

Vasodilation is the widening or increase in diameter of blood vessels, particularly the involuntary relaxation of the smooth muscle in the tunica media (middle layer) of the arteriole walls. This results in an increase in blood flow and a decrease in vascular resistance. Vasodilation can occur due to various physiological and pathophysiological stimuli, such as local metabolic demands, neural signals, or pharmacological agents. It plays a crucial role in regulating blood pressure, tissue perfusion, and thermoregulation.

Acetylcholine is a neurotransmitter, a type of chemical messenger that transmits signals across a chemical synapse from one neuron (nerve cell) to another "target" neuron, muscle cell, or gland cell. It is involved in both peripheral and central nervous system functions.

In the peripheral nervous system, acetylcholine acts as a neurotransmitter at the neuromuscular junction, where it transmits signals from motor neurons to activate muscles. Acetylcholine also acts as a neurotransmitter in the autonomic nervous system, where it is involved in both the sympathetic and parasympathetic systems.

In the central nervous system, acetylcholine plays a role in learning, memory, attention, and arousal. Disruptions in cholinergic neurotransmission have been implicated in several neurological disorders, including Alzheimer's disease, Parkinson's disease, and myasthenia gravis.

Acetylcholine is synthesized from choline and acetyl-CoA by the enzyme choline acetyltransferase and is stored in vesicles at the presynaptic terminal of the neuron. When a nerve impulse arrives, the vesicles fuse with the presynaptic membrane, releasing acetylcholine into the synapse. The acetylcholine then binds to receptors on the postsynaptic membrane, triggering a response in the target cell. Acetylcholine is subsequently degraded by the enzyme acetylcholinesterase, which terminates its action and allows for signal transduction to be repeated.

Vascular resistance is a measure of the opposition to blood flow within a vessel or a group of vessels, typically expressed in units of mmHg/(mL/min) or sometimes as dynes*sec/cm^5. It is determined by the diameter and length of the vessels, as well as the viscosity of the blood flowing through them. In general, a decrease in vessel diameter, an increase in vessel length, or an increase in blood viscosity will result in an increase in vascular resistance, while an increase in vessel diameter, a decrease in vessel length, or a decrease in blood viscosity will result in a decrease in vascular resistance. Vascular resistance is an important concept in the study of circulation and cardiovascular physiology because it plays a key role in determining blood pressure and blood flow within the body.

Nitric oxide (NO) is a molecule made up of one nitrogen atom and one oxygen atom. In the body, it is a crucial signaling molecule involved in various physiological processes such as vasodilation, immune response, neurotransmission, and inhibition of platelet aggregation. It is produced naturally by the enzyme nitric oxide synthase (NOS) from the amino acid L-arginine. Inhaled nitric oxide is used medically to treat pulmonary hypertension in newborns and adults, as it helps to relax and widen blood vessels, improving oxygenation and blood flow.

Regional blood flow (RBF) refers to the rate at which blood flows through a specific region or organ in the body, typically expressed in milliliters per minute per 100 grams of tissue (ml/min/100g). It is an essential physiological parameter that reflects the delivery of oxygen and nutrients to tissues while removing waste products. RBF can be affected by various factors such as metabolic demands, neural regulation, hormonal influences, and changes in blood pressure or vascular resistance. Measuring RBF is crucial for understanding organ function, diagnosing diseases, and evaluating the effectiveness of treatments.

Nitroglycerin, also known as glyceryl trinitrate, is a medication used primarily for the treatment of angina pectoris (chest pain due to coronary artery disease) and hypertensive emergencies (severe high blood pressure). It belongs to a class of drugs called nitrates or organic nitrites.

Nitroglycerin works by relaxing and dilating the smooth muscle in blood vessels, which leads to decreased workload on the heart and increased oxygen delivery to the myocardium (heart muscle). This results in reduced symptoms of angina and improved cardiac function during hypertensive emergencies.

The drug is available in various forms, including sublingual tablets, sprays, transdermal patches, ointments, and intravenous solutions. The choice of formulation depends on the specific clinical situation and patient needs. Common side effects of nitroglycerin include headache, dizziness, and hypotension (low blood pressure).

The forearm is the region of the upper limb between the elbow and the wrist. It consists of two bones, the radius and ulna, which are located side by side and run parallel to each other. The forearm is responsible for movements such as flexion, extension, supination, and pronation of the hand and wrist.

The endothelium is a thin layer of simple squamous epithelial cells that lines the interior surface of blood vessels, lymphatic vessels, and heart chambers. The vascular endothelium, specifically, refers to the endothelial cells that line the blood vessels. These cells play a crucial role in maintaining vascular homeostasis by regulating vasomotor tone, coagulation, platelet activation, inflammation, and permeability of the vessel wall. They also contribute to the growth and repair of the vascular system and are involved in various pathological processes such as atherosclerosis, hypertension, and diabetes.

Hydralazine is an antihypertensive medication, which means it is used to treat high blood pressure. It works by relaxing and widening the blood vessels, making it easier for the heart to pump blood through the body. This can help reduce the workload on the heart and lower blood pressure. Hydralazine is available in oral tablet form and is typically prescribed to be taken several times a day.

Hydralazine belongs to a class of medications called vasodilators, which work by relaxing the muscle in the walls of the blood vessels, causing them to widen. This increases the amount of blood that can flow through the blood vessels and reduces the pressure within them. Hydralazine is often used in combination with other medications to treat high blood pressure.

It's important to note that hydralazine should be used under the close supervision of a healthcare provider, as it can cause side effects such as headache, dizziness, and rapid heartbeat. It may also interact with certain other medications, so it is important to inform your doctor of all medications you are taking before starting hydralazine.

Bradykinin is a naturally occurring peptide in the human body, consisting of nine amino acids. It is a potent vasodilator and increases the permeability of blood vessels, causing a local inflammatory response. Bradykinin is formed from the breakdown of certain proteins, such as kininogen, by enzymes called kininases or proteases, including kallikrein. It plays a role in several physiological processes, including pain transmission, blood pressure regulation, and the immune response. In some pathological conditions, such as hereditary angioedema, bradykinin levels can increase excessively, leading to symptoms like swelling, redness, and pain.

Vasoconstriction is a medical term that refers to the narrowing of blood vessels due to the contraction of the smooth muscle in their walls. This process decreases the diameter of the lumen (the inner space of the blood vessel) and reduces blood flow through the affected vessels. Vasoconstriction can occur throughout the body, but it is most noticeable in the arterioles and precapillary sphincters, which control the amount of blood that flows into the capillary network.

The autonomic nervous system, specifically the sympathetic division, plays a significant role in regulating vasoconstriction through the release of neurotransmitters like norepinephrine (noradrenaline). Various hormones and chemical mediators, such as angiotensin II, endothelin-1, and serotonin, can also induce vasoconstriction.

Vasoconstriction is a vital physiological response that helps maintain blood pressure and regulate blood flow distribution in the body. However, excessive or prolonged vasoconstriction may contribute to several pathological conditions, including hypertension, stroke, and peripheral vascular diseases.

Hemodynamics is the study of how blood flows through the cardiovascular system, including the heart and the vascular network. It examines various factors that affect blood flow, such as blood volume, viscosity, vessel length and diameter, and pressure differences between different parts of the circulatory system. Hemodynamics also considers the impact of various physiological and pathological conditions on these variables, and how they in turn influence the function of vital organs and systems in the body. It is a critical area of study in fields such as cardiology, anesthesiology, and critical care medicine.

Blood pressure is the force exerted by circulating blood on the walls of the blood vessels. It is measured in millimeters of mercury (mmHg) and is given as two figures:

1. Systolic pressure: This is the pressure when the heart pushes blood out into the arteries.
2. Diastolic pressure: This is the pressure when the heart rests between beats, allowing it to fill with blood.

Normal blood pressure for adults is typically around 120/80 mmHg, although this can vary slightly depending on age, sex, and other factors. High blood pressure (hypertension) is generally considered to be a reading of 130/80 mmHg or higher, while low blood pressure (hypotension) is usually defined as a reading below 90/60 mmHg. It's important to note that blood pressure can fluctuate throughout the day and may be affected by factors such as stress, physical activity, and medication use.

NG-Nitroarginine Methyl Ester (L-NAME) is not a medication, but rather a research chemical used in scientific studies. It is an inhibitor of nitric oxide synthase, an enzyme that synthesizes nitric oxide, a molecule involved in the relaxation of blood vessels.

Therefore, L-NAME is often used in experiments to investigate the role of nitric oxide in various physiological and pathophysiological processes. It is important to note that the use of L-NAME in humans is not approved for therapeutic purposes due to its potential side effects, which can include hypertension, decreased renal function, and decreased cerebral blood flow.

Epoprostenol is a medication that belongs to a class of drugs called prostaglandins. It is a synthetic analog of a natural substance in the body called prostacyclin, which widens blood vessels and has anti-platelet effects. Epoprostenol is used to treat pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the arteries that supply blood to the lungs.

Epoprostenol works by relaxing the smooth muscle in the walls of the pulmonary arteries, which reduces the resistance to blood flow and lowers the pressure within these vessels. This helps improve symptoms such as shortness of breath, fatigue, and chest pain, and can also prolong survival in people with PAH.

Epoprostenol is administered continuously through a small pump that delivers the medication directly into the bloodstream. It is a potent vasodilator, which means it can cause a sudden drop in blood pressure if not given carefully. Therefore, it is usually started in a hospital setting under close medical supervision.

Common side effects of epoprostenol include headache, flushing, jaw pain, nausea, vomiting, diarrhea, and muscle or joint pain. More serious side effects can include bleeding, infection at the site of the catheter, and an allergic reaction to the medication.

Calcitonin gene-related peptide (CGRP) is a neurotransmitter and vasodilator peptide that is widely distributed in the nervous system. It is encoded by the calcitonin gene, which also encodes calcitonin and catestatin. CGRP is produced and released by sensory nerves and plays important roles in pain transmission, modulation of inflammation, and regulation of blood flow.

CGRP exists as two forms, α-CGRP and β-CGRP, which differ slightly in their amino acid sequences but have similar biological activities. α-CGRP is found primarily in the central and peripheral nervous systems, while β-CGRP is expressed mainly in the gastrointestinal tract.

CGRP exerts its effects by binding to specific G protein-coupled receptors, which are widely distributed in various tissues, including blood vessels, smooth muscles, and sensory neurons. Activation of CGRP receptors leads to increased intracellular cyclic AMP levels, activation of protein kinase A, and subsequent relaxation of vascular smooth muscle, resulting in vasodilation.

CGRP has been implicated in several clinical conditions, including migraine, cluster headache, and inflammatory pain. Inhibition of CGRP signaling has emerged as a promising therapeutic strategy for the treatment of these disorders.

Vasoconstrictor agents are substances that cause the narrowing of blood vessels by constricting the smooth muscle in their walls. This leads to an increase in blood pressure and a decrease in blood flow. They work by activating the sympathetic nervous system, which triggers the release of neurotransmitters such as norepinephrine and epinephrine that bind to alpha-adrenergic receptors on the smooth muscle cells of the blood vessel walls, causing them to contract.

Vasoconstrictor agents are used medically for a variety of purposes, including:

* Treating hypotension (low blood pressure)
* Controlling bleeding during surgery or childbirth
* Relieving symptoms of nasal congestion in conditions such as the common cold or allergies

Examples of vasoconstrictor agents include phenylephrine, oxymetazoline, and epinephrine. It's important to note that prolonged use or excessive doses of vasoconstrictor agents can lead to rebound congestion and other adverse effects, so they should be used with caution and under the guidance of a healthcare professional.

The mesenteric arteries are the arteries that supply oxygenated blood to the intestines. There are three main mesenteric arteries: the superior mesenteric artery, which supplies blood to the small intestine (duodenum to two-thirds of the transverse colon) and large intestine (cecum, ascending colon, and the first part of the transverse colon); the inferior mesenteric artery, which supplies blood to the distal third of the transverse colon, descending colon, sigmoid colon, and rectum; and the middle colic artery, which is a branch of the superior mesenteric artery that supplies blood to the transverse colon. These arteries are important in maintaining adequate blood flow to the intestines to support digestion and absorption of nutrients.

Hyperemia is a medical term that refers to an increased flow or accumulation of blood in certain capillaries or vessels within an organ or tissue, resulting in its redness and warmth. This can occur due to various reasons such as physical exertion, emotional excitement, local injury, or specific medical conditions.

There are two types of hyperemia: active and passive. Active hyperemia is a physiological response where the blood flow increases as a result of the metabolic demands of the organ or tissue. For example, during exercise, muscles require more oxygen and nutrients, leading to an increase in blood flow. Passive hyperemia, on the other hand, occurs when there is a blockage in the venous outflow, causing the blood to accumulate in the affected area. This can result from conditions like thrombosis or vasoconstriction.

It's important to note that while hyperemia itself is not a disease, it can be a symptom of various underlying medical conditions and should be evaluated by a healthcare professional if it persists or is accompanied by other symptoms.

Coronary circulation refers to the circulation of blood in the coronary vessels, which supply oxygenated blood to the heart muscle (myocardium) and drain deoxygenated blood from it. The coronary circulation system includes two main coronary arteries - the left main coronary artery and the right coronary artery - that branch off from the aorta just above the aortic valve. These arteries further divide into smaller branches, which supply blood to different regions of the heart muscle.

The left main coronary artery divides into two branches: the left anterior descending (LAD) artery and the left circumflex (LCx) artery. The LAD supplies blood to the front and sides of the heart, while the LCx supplies blood to the back and sides of the heart. The right coronary artery supplies blood to the lower part of the heart, including the right ventricle and the bottom portion of the left ventricle.

The veins that drain the heart muscle include the great cardiac vein, the middle cardiac vein, and the small cardiac vein, which merge to form the coronary sinus. The coronary sinus empties into the right atrium, allowing deoxygenated blood to enter the right side of the heart and be pumped to the lungs for oxygenation.

Coronary circulation is essential for maintaining the health and function of the heart muscle, as it provides the necessary oxygen and nutrients required for proper contraction and relaxation of the myocardium. Any disruption or blockage in the coronary circulation system can lead to serious consequences, such as angina, heart attack, or even death.

Pulmonary circulation refers to the process of blood flow through the lungs, where blood picks up oxygen and releases carbon dioxide. This is a vital part of the overall circulatory system, which delivers nutrients and oxygen to the body's cells while removing waste products like carbon dioxide.

In pulmonary circulation, deoxygenated blood from the systemic circulation returns to the right atrium of the heart via the superior and inferior vena cava. The blood then moves into the right ventricle through the tricuspid valve and gets pumped into the pulmonary artery when the right ventricle contracts.

The pulmonary artery divides into smaller vessels called arterioles, which further branch into a vast network of tiny capillaries in the lungs. Here, oxygen from the alveoli diffuses into the blood, binding to hemoglobin in red blood cells, while carbon dioxide leaves the blood and is exhaled through the nose or mouth.

The now oxygenated blood collects in venules, which merge to form pulmonary veins. These veins transport the oxygen-rich blood back to the left atrium of the heart, where it enters the systemic circulation once again. This continuous cycle enables the body's cells to receive the necessary oxygen and nutrients for proper functioning while disposing of waste products.

Adenosine is a purine nucleoside that is composed of a sugar (ribose) and the base adenine. It plays several important roles in the body, including serving as a precursor for the synthesis of other molecules such as ATP, NAD+, and RNA.

In the medical context, adenosine is perhaps best known for its use as a pharmaceutical agent to treat certain cardiac arrhythmias. When administered intravenously, it can help restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT) by slowing conduction through the atrioventricular node and interrupting the reentry circuit responsible for the arrhythmia.

Adenosine can also be used as a diagnostic tool to help differentiate between narrow-complex tachycardias of supraventricular origin and those that originate from below the ventricles (such as ventricular tachycardia). This is because adenosine will typically terminate PSVT but not affect the rhythm of VT.

It's worth noting that adenosine has a very short half-life, lasting only a few seconds in the bloodstream. This means that its effects are rapidly reversible and generally well-tolerated, although some patients may experience transient symptoms such as flushing, chest pain, or shortness of breath.

Pulmonary hypertension is a medical condition characterized by increased blood pressure in the pulmonary arteries, which are the blood vessels that carry blood from the right side of the heart to the lungs. This results in higher than normal pressures in the pulmonary circulation and can lead to various symptoms and complications.

Pulmonary hypertension is typically defined as a mean pulmonary artery pressure (mPAP) greater than or equal to 25 mmHg at rest, as measured by right heart catheterization. The World Health Organization (WHO) classifies pulmonary hypertension into five groups based on the underlying cause:

1. Pulmonary arterial hypertension (PAH): This group includes idiopathic PAH, heritable PAH, drug-induced PAH, and associated PAH due to conditions such as connective tissue diseases, HIV infection, portal hypertension, congenital heart disease, and schistosomiasis.
2. Pulmonary hypertension due to left heart disease: This group includes conditions that cause elevated left atrial pressure, such as left ventricular systolic or diastolic dysfunction, valvular heart disease, and congenital cardiovascular shunts.
3. Pulmonary hypertension due to lung diseases and/or hypoxia: This group includes chronic obstructive pulmonary disease (COPD), interstitial lung disease, sleep-disordered breathing, alveolar hypoventilation disorders, and high altitude exposure.
4. Chronic thromboembolic pulmonary hypertension (CTEPH): This group includes persistent obstruction of the pulmonary arteries due to organized thrombi or emboli.
5. Pulmonary hypertension with unclear and/or multifactorial mechanisms: This group includes hematologic disorders, systemic disorders, metabolic disorders, and other conditions that can cause pulmonary hypertension but do not fit into the previous groups.

Symptoms of pulmonary hypertension may include shortness of breath, fatigue, chest pain, lightheadedness, and syncope (fainting). Diagnosis typically involves a combination of medical history, physical examination, imaging studies, and invasive testing such as right heart catheterization. Treatment depends on the underlying cause but may include medications, oxygen therapy, pulmonary rehabilitation, and, in some cases, surgical intervention.

Coronary vessels refer to the network of blood vessels that supply oxygenated blood and nutrients to the heart muscle, also known as the myocardium. The two main coronary arteries are the left main coronary artery and the right coronary artery.

The left main coronary artery branches off into the left anterior descending artery (LAD) and the left circumflex artery (LCx). The LAD supplies blood to the front of the heart, while the LCx supplies blood to the side and back of the heart.

The right coronary artery supplies blood to the right lower part of the heart, including the right atrium and ventricle, as well as the back of the heart.

Coronary vessel disease (CVD) occurs when these vessels become narrowed or blocked due to the buildup of plaque, leading to reduced blood flow to the heart muscle. This can result in chest pain, shortness of breath, or a heart attack.

The vasomotor system is a part of the autonomic nervous system that controls the diameter of blood vessels, particularly the smooth muscle in the walls of arterioles and precapillary sphincters. It regulates blood flow to different parts of the body by constricting or dilating these vessels. The vasomotor center located in the medulla oblongata of the brainstem controls the system, receiving input from various sensory receptors and modulating the sympathetic and parasympathetic nervous systems' activity. Vasoconstriction decreases blood flow, while vasodilation increases it.

Splanchnic circulation refers to the blood flow to the visceral organs, including the gastrointestinal tract, pancreas, spleen, and liver. These organs receive a significant portion of the cardiac output, with approximately 25-30% of the total restingly going to the splanchnic circulation. The splanchnic circulation is regulated by a complex interplay of neural and hormonal mechanisms that help maintain adequate blood flow to these vital organs while also allowing for the distribution of blood to other parts of the body as needed.

The splanchnic circulation is unique in its ability to vasodilate and increase blood flow significantly in response to meals or other stimuli, such as stress or hormonal changes. This increased blood flow helps support the digestive process and absorption of nutrients. At the same time, the body must carefully regulate this blood flow to prevent a significant drop in blood pressure or overloading the heart with too much work.

Overall, the splanchnic circulation plays a critical role in maintaining the health and function of the body's vital organs, and dysregulation of this system can contribute to various diseases, including digestive disorders, liver disease, and cardiovascular disease.

Omega-N-Methylarginine (also known as NG, NG-dimethyl-L-arginine) is not a commonly used medical term and it's not a well-known compound in medicine. However, it is a form of methylated arginine that can be found in the body.

Methylated arginines are a group of compounds that are generated through the post-translational modification of proteins by enzymes called protein arginine methyltransferases (PRMTs). These modifications play important roles in various cellular processes, including gene expression and signal transduction.

Omega-N-Methylarginine is a specific type of methylated arginine that has two methyl groups attached to the nitrogen atom at the end of the side chain (omega position) of the amino acid arginine. It can be formed by the action of PRMTs on proteins, and it may have various biological functions in the body. However, its specific medical significance is not well-established, and more research is needed to fully understand its role in health and disease.

Nitric Oxide Synthase (NOS) is a group of enzymes that catalyze the production of nitric oxide (NO) from L-arginine. There are three distinct isoforms of NOS, each with different expression patterns and functions:

1. Neuronal Nitric Oxide Synthase (nNOS or NOS1): This isoform is primarily expressed in the nervous system and plays a role in neurotransmission, synaptic plasticity, and learning and memory processes.
2. Inducible Nitric Oxide Synthase (iNOS or NOS2): This isoform is induced by various stimuli such as cytokines, lipopolysaccharides, and hypoxia in a variety of cells including immune cells, endothelial cells, and smooth muscle cells. iNOS produces large amounts of NO, which functions as a potent effector molecule in the immune response, particularly in the defense against microbial pathogens.
3. Endothelial Nitric Oxide Synthase (eNOS or NOS3): This isoform is constitutively expressed in endothelial cells and produces low levels of NO that play a crucial role in maintaining vascular homeostasis by regulating vasodilation, inhibiting platelet aggregation, and preventing smooth muscle cell proliferation.

Overall, NOS plays an essential role in various physiological processes, including neurotransmission, immune response, cardiovascular function, and respiratory regulation. Dysregulation of NOS activity has been implicated in several pathological conditions such as hypertension, atherosclerosis, neurodegenerative diseases, and inflammatory disorders.

A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.

The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.

The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.

In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.

I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.

If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.

Arginine is an α-amino acid that is classified as a semi-essential or conditionally essential amino acid, depending on the developmental stage and health status of the individual. The adult human body can normally synthesize sufficient amounts of arginine to meet its needs, but there are certain circumstances, such as periods of rapid growth or injury, where the dietary intake of arginine may become necessary.

The chemical formula for arginine is C6H14N4O2. It has a molecular weight of 174.20 g/mol and a pKa value of 12.48. Arginine is a basic amino acid, which means that it contains a side chain with a positive charge at physiological pH levels. The side chain of arginine is composed of a guanidino group, which is a functional group consisting of a nitrogen atom bonded to three methyl groups.

In the body, arginine plays several important roles. It is a precursor for the synthesis of nitric oxide, a molecule that helps regulate blood flow and immune function. Arginine is also involved in the detoxification of ammonia, a waste product produced by the breakdown of proteins. Additionally, arginine can be converted into other amino acids, such as ornithine and citrulline, which are involved in various metabolic processes.

Foods that are good sources of arginine include meat, poultry, fish, dairy products, nuts, seeds, and legumes. Arginine supplements are available and may be used for a variety of purposes, such as improving exercise performance, enhancing wound healing, and boosting immune function. However, it is important to consult with a healthcare provider before taking arginine supplements, as they can interact with certain medications and have potential side effects.

Arterioles are small branches of arteries that play a crucial role in regulating blood flow and blood pressure within the body's circulatory system. They are the smallest type of blood vessels that have muscular walls, which allow them to contract or dilate in response to various physiological signals.

Arterioles receive blood from upstream arteries and deliver it to downstream capillaries, where the exchange of oxygen, nutrients, and waste products occurs between the blood and surrounding tissues. The contraction of arteriolar muscles can reduce the diameter of these vessels, causing increased resistance to blood flow and leading to a rise in blood pressure upstream. Conversely, dilation of arterioles reduces resistance and allows for greater blood flow at a lower pressure.

The regulation of arteriolar tone is primarily controlled by the autonomic nervous system, local metabolic factors, and various hormones. This fine-tuning of arteriolar diameter enables the body to maintain adequate blood perfusion to vital organs while also controlling overall blood pressure and distribution.

Endothelium-dependent relaxing factors (EDRFs) are substances that are released by the endothelial cells, which line the interior surface of blood vessels. These factors cause relaxation of the smooth muscle in the vessel wall, leading to vasodilation and an increase in blood flow. One of the most well-known EDRFs is nitric oxide (NO), which is produced from the amino acid L-arginine by the enzyme nitric oxide synthase. Other substances that have been identified as EDRFs include prostacyclin and endothelium-derived hyperpolarizing factor (EDHF). These factors play important roles in the regulation of vascular tone, blood pressure, and inflammation.

Plethysmography is a non-invasive medical technique used to measure changes in volume or blood flow within an organ or body part, typically in the lungs or extremities. There are several types of plethysmography, including:

1. **Whole Body Plethysmography (WBP):** This type of plethysmography is used to assess lung function and volumes by measuring changes in pressure within a sealed chamber that contains the patient's entire body except for their head. The patient breathes normally while wearing a nose clip, allowing technicians to analyze respiratory patterns, airflow, and lung volume changes.
2. **Segmental or Local Plethysmography:** This technique measures volume or blood flow changes in specific body parts, such as the limbs or digits. It can help diagnose and monitor conditions affecting peripheral circulation, like deep vein thrombosis, arterial occlusive disease, or Raynaud's phenomenon.
3. **Impedance Plethysmography (IPG):** This non-invasive method uses electrical impedance to estimate changes in blood volume within an organ or body part. By applying a small electrical current and measuring the opposition to flow (impedance), technicians can determine variations in blood volume, which can help diagnose conditions like deep vein thrombosis or heart failure.
4. **Optical Plethysmography:** This technique uses light to measure changes in blood volume, typically in the skin or mucous membranes. By shining a light on the area and analyzing the reflected or transmitted light, technicians can detect variations in blood volume related to cardiac output, respiration, or other physiological factors.

Overall, plethysmography is an essential tool for diagnosing and monitoring various medical conditions affecting circulation, respiratory function, and organ volumes.

A smooth muscle within the vascular system refers to the involuntary, innervated muscle that is found in the walls of blood vessels. These muscles are responsible for controlling the diameter of the blood vessels, which in turn regulates blood flow and blood pressure. They are called "smooth" muscles because their individual muscle cells do not have the striations, or cross-striped patterns, that are observed in skeletal and cardiac muscle cells. Smooth muscle in the vascular system is controlled by the autonomic nervous system and by hormones, and can contract or relax slowly over a period of time.

Adrenomedullin is a hormone that is produced and released by the adrenal glands, specifically from the chromaffin cells in the adrenal medulla. It is a small peptide made up of 52 amino acids and has various physiological functions, including vasodilation, bronchodilation, and inhibition of cell growth.

Adrenomedullin acts as a potent vasodilator by binding to specific G protein-coupled receptors in the vascular smooth muscle cells, leading to relaxation of the blood vessels. It also has a role in regulating blood pressure and fluid balance in the body.

In addition to its effects on the cardiovascular system, adrenomedullin has been shown to have anti-inflammatory and neuroprotective properties. It is involved in various physiological processes such as wound healing, tissue repair, and angiogenesis (the formation of new blood vessels).

Abnormal levels of adrenomedullin have been implicated in several disease states, including hypertension, heart failure, sepsis, and cancer. Therefore, measuring adrenomedullin levels in the body can provide valuable diagnostic and prognostic information for these conditions.

Renal circulation refers to the blood flow specifically dedicated to the kidneys. The main function of the kidneys is to filter waste and excess fluids from the blood, which then get excreted as urine. To perform this function efficiently, the kidneys receive a substantial amount of the body's total blood supply - about 20-25% in a resting state.

The renal circulation process begins when deoxygenated blood from the rest of the body returns to the right side of the heart and is pumped into the lungs for oxygenation. Oxygen-rich blood then leaves the left side of the heart through the aorta, the largest artery in the body.

A portion of this oxygen-rich blood moves into the renal arteries, which branch directly from the aorta and supply each kidney with blood. Within the kidneys, these arteries divide further into smaller vessels called afferent arterioles, which feed into a network of tiny capillaries called the glomerulus within each nephron (the functional unit of the kidney).

The filtration process occurs in the glomeruli, where waste materials and excess fluids are separated from the blood. The resulting filtrate then moves through another set of capillaries, the peritubular capillaries, which surround the renal tubules (the part of the nephron that reabsorbs necessary substances back into the bloodstream).

The now-deoxygenated blood from the kidneys' capillary network coalesces into venules and then merges into the renal veins, which ultimately drain into the inferior vena cava and return the blood to the right side of the heart. This highly specialized circulation system allows the kidneys to efficiently filter waste while maintaining appropriate blood volume and composition.

Cromakalim is a pharmacological agent, specifically a potassium channel opener, that was investigated for its potential therapeutic effects in the treatment of cardiovascular diseases such as hypertension and angina. Potassium channel openers work by relaxing smooth muscle cells in blood vessels, which leads to vasodilation and decreased blood pressure. However, cromakalim was never approved for clinical use due to its associated side effects, including negative inotropic effects on the heart and potential proarrhythmic properties.

Indomethacin is a non-steroidal anti-inflammatory drug (NSAID) that is commonly used to reduce pain, inflammation, and fever. It works by inhibiting the activity of certain enzymes in the body, including cyclooxygenase (COX), which plays a role in producing prostaglandins, chemicals involved in the inflammatory response.

Indomethacin is available in various forms, such as capsules, suppositories, and injectable solutions, and is used to treat a wide range of conditions, including rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout, and bursitis. It may also be used to relieve pain and reduce fever in other conditions, such as dental procedures or after surgery.

Like all NSAIDs, indomethacin can have side effects, including stomach ulcers, bleeding, and kidney damage, especially when taken at high doses or for long periods of time. It may also increase the risk of heart attack and stroke. Therefore, it is important to use indomethacin only as directed by a healthcare provider and to report any unusual symptoms or side effects promptly.

Nitro-L-arginine or Nitroarginine is not a medical term per se, but it is a chemical compound that is sometimes used in medical research and experiments. It is a salt of nitric acid and L-arginine, an amino acid that is important for the functioning of the body.

Nitroarginine is known to inhibit the production of nitric oxide, a molecule that plays a role in various physiological processes such as blood flow regulation, immune response, and neurotransmission. As a result, nitroarginine has been used in research to study the effects of reduced nitric oxide levels on different systems in the body.

It's worth noting that nitroarginine is not approved for use as a medication in humans, and its use is generally limited to laboratory settings.

Dipyridamole is a medication that belongs to a class of drugs called antiplatelet agents. It works by preventing platelets in your blood from sticking together to form clots. Dipyridamole is often used in combination with aspirin to prevent stroke and other complications in people who have had a heart valve replacement or a type of irregular heartbeat called atrial fibrillation.

Dipyridamole can also be used as a stress agent in myocardial perfusion imaging studies, which are tests used to evaluate blood flow to the heart. When used for this purpose, dipyridamole is given intravenously and works by dilating the blood vessels in the heart, allowing more blood to flow through them and making it easier to detect areas of reduced blood flow.

The most common side effects of dipyridamole include headache, dizziness, and gastrointestinal symptoms such as diarrhea, nausea, and vomiting. In rare cases, dipyridamole can cause more serious side effects, such as allergic reactions, abnormal heart rhythms, or low blood pressure. It is important to take dipyridamole exactly as directed by your healthcare provider and to report any unusual symptoms or side effects promptly.

Minoxidil is a medication that is primarily used to treat hair loss. It is a vasodilator, which means it widens blood vessels and improves blood flow. When applied to the scalp, it helps to stimulate hair growth and slows down hair loss. It is available in topical form as a solution or foam, and is usually applied once or twice a day. Minoxidil is not intended for use in children, and women who are pregnant or breastfeeding should consult with their doctor before using it.

It's important to note that minoxidil does not work for everyone, and it may take several months of regular use before any new hair growth is seen. Additionally, if the medication is discontinued, any hair gained during treatment will likely be lost over time. Common side effects of minoxidil include scalp irritation, unwanted hair growth on other parts of the body, and changes in the color or texture of existing hair. It's important to follow the instructions provided by a healthcare professional when using minoxidil.

The pulmonary artery is a large blood vessel that carries deoxygenated blood from the right ventricle of the heart to the lungs for oxygenation. It divides into two main branches, the right and left pulmonary arteries, which further divide into smaller vessels called arterioles, and then into a vast network of capillaries in the lungs where gas exchange occurs. The thin walls of these capillaries allow oxygen to diffuse into the blood and carbon dioxide to diffuse out, making the blood oxygen-rich before it is pumped back to the left side of the heart through the pulmonary veins. This process is crucial for maintaining proper oxygenation of the body's tissues and organs.

Isosorbide dinitrate is a medication that belongs to a class of drugs called nitrates. It is primarily used in the prevention and treatment of angina pectoris, which is chest pain caused by reduced blood flow to the heart muscle.

The medical definition of Isosorbide dinitrate is:

A soluble nitrate ester used in the prevention and treatment of anginal attacks. It acts by dilating coronary and peripheral arteries and veins, thereby reducing cardiac workload and increasing oxygen delivery to the heart muscle. Its therapeutic effects are attributed to its conversion to nitric oxide, a potent vasodilator, in the body. Isosorbide dinitrate is available in various forms, including tablets, capsules, and oral solutions, and is typically taken 2-3 times daily for optimal effect.

Arteries are blood vessels that carry oxygenated blood away from the heart to the rest of the body. They have thick, muscular walls that can withstand the high pressure of blood being pumped out of the heart. Arteries branch off into smaller vessels called arterioles, which further divide into a vast network of tiny capillaries where the exchange of oxygen, nutrients, and waste occurs between the blood and the body's cells. After passing through the capillary network, deoxygenated blood collects in venules, then merges into veins, which return the blood back to the heart.

Biological factors are the aspects related to living organisms, including their genes, evolution, physiology, and anatomy. These factors can influence an individual's health status, susceptibility to diseases, and response to treatments. Biological factors can be inherited or acquired during one's lifetime and can interact with environmental factors to shape a person's overall health. Examples of biological factors include genetic predisposition, hormonal imbalances, infections, and chronic medical conditions.

Microcirculation is the circulation of blood in the smallest blood vessels, including arterioles, venules, and capillaries. It's responsible for the delivery of oxygen and nutrients to the tissues and the removal of waste products. The microcirculation plays a crucial role in maintaining tissue homeostasis and is regulated by various physiological mechanisms such as autonomic nervous system activity, local metabolic factors, and hormones.

Impairment of microcirculation can lead to tissue hypoxia, inflammation, and organ dysfunction, which are common features in several diseases, including diabetes, hypertension, sepsis, and ischemia-reperfusion injury. Therefore, understanding the structure and function of the microcirculation is essential for developing new therapeutic strategies to treat these conditions.

Enzyme inhibitors are substances that bind to an enzyme and decrease its activity, preventing it from catalyzing a chemical reaction in the body. They can work by several mechanisms, including blocking the active site where the substrate binds, or binding to another site on the enzyme to change its shape and prevent substrate binding. Enzyme inhibitors are often used as drugs to treat various medical conditions, such as high blood pressure, abnormal heart rhythms, and bacterial infections. They can also be found naturally in some foods and plants, and can be used in research to understand enzyme function and regulation.

Prostaglandins are naturally occurring, lipid-derived hormones that play various important roles in the human body. They are produced in nearly every tissue in response to injury or infection, and they have diverse effects depending on the site of release and the type of prostaglandin. Some of their functions include:

1. Regulation of inflammation: Prostaglandins contribute to the inflammatory response by increasing vasodilation, promoting fluid accumulation, and sensitizing pain receptors, which can lead to symptoms such as redness, heat, swelling, and pain.
2. Modulation of gastrointestinal functions: Prostaglandins protect the stomach lining from acid secretion and promote mucus production, maintaining the integrity of the gastric mucosa. They also regulate intestinal motility and secretion.
3. Control of renal function: Prostaglandins help regulate blood flow to the kidneys, maintain sodium balance, and control renin release, which affects blood pressure and fluid balance.
4. Regulation of smooth muscle contraction: Prostaglandins can cause both relaxation and contraction of smooth muscles in various tissues, such as the uterus, bronchioles, and vascular system.
5. Modulation of platelet aggregation: Some prostaglandins inhibit platelet aggregation, preventing blood clots from forming too quickly or becoming too large.
6. Reproductive system regulation: Prostaglandins are involved in the menstrual cycle, ovulation, and labor induction by promoting uterine contractions.
7. Neurotransmission: Prostaglandins can modulate neurotransmitter release and neuronal excitability, affecting pain perception, mood, and cognition.

Prostaglandins exert their effects through specific G protein-coupled receptors (GPCRs) found on the surface of target cells. There are several distinct types of prostaglandins (PGs), including PGD2, PGE2, PGF2α, PGI2 (prostacyclin), and thromboxane A2 (TXA2). Each type has unique functions and acts through specific receptors. Prostaglandins are synthesized from arachidonic acid, a polyunsaturated fatty acid derived from membrane phospholipids, by the action of cyclooxygenase (COX) enzymes. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, inhibit COX activity, reducing prostaglandin synthesis and providing analgesic, anti-inflammatory, and antipyretic effects.

Heart rate is the number of heartbeats per unit of time, often expressed as beats per minute (bpm). It can vary significantly depending on factors such as age, physical fitness, emotions, and overall health status. A resting heart rate between 60-100 bpm is generally considered normal for adults, but athletes and individuals with high levels of physical fitness may have a resting heart rate below 60 bpm due to their enhanced cardiovascular efficiency. Monitoring heart rate can provide valuable insights into an individual's health status, exercise intensity, and response to various treatments or interventions.

Benzopyrans are a class of chemical compounds that contain a benzene ring fused to a pyran ring. They are also known as chromenes. Benzopyrans can be found in various natural sources, including plants and fungi, and have been studied for their potential biological activities. Some benzopyrans have been found to have anti-inflammatory, antioxidant, and anticancer properties. However, some benzopyrans can also be toxic or have other adverse health effects, so it is important to study their properties and potential uses carefully.

Rosendorff C (June 1993). "Beta-blocking agents with vasodilator activity". Journal of Hypertension Supplement. 11 (4): S37-40 ... Agents specifically labeled for migraine prophylaxis Timolol, propranolol Propranolol is the only agent indicated for the ... timolol Agents specifically labeled for cardiac arrhythmia Esmolol, sotalol, landiolol (Japan) Agents specifically labeled for ... depending on the concentration of the agent (beta blocker) and the concentration of the antagonized agent (usually an ...
... is a vasodilator and an anti-sickling agent. Alavi JB (May 1984). "Sickle cell anemia. Pathophysiology and treatment ...
... is a precursor to bencyclane, a spasmolytic agent and vasodilator. Pimelic acid is produced by the oxidative ...
... vasodilator agents Local: ACE inhibitors, ciclosporin, tacrolimus. Proximal convoluted tubule: Aminoglycoside antibiotics (e.g ...
... is a vasodilator which has been used as an antianginal agent. Morton IK, Hall JM (October 2012). "Etafenone". Concise ... Vasodilators, Aromatic ketones, Phenol ethers, Diethylamino compounds, All stub articles, Cardiovascular system drug stubs). ... Dictionary of Pharmacological Agents : Properties and Synonyms. New York: Springer. p. 115. ISBN 9789401059077. v t e (Articles ...
Oxyacanthine serves as a sympatholytic agent, an antagonist to epinephrine, and a vasodilator. Tubocurarine, a potent ...
... an antiplatelet and vasodilator agent on gentamicin-induced nephrotoxicity in rats". Pharmacological Research. 44 (4): 321-328 ... Trapidil is a vasodilator and an antiplatelet drug. It also acts as an antagonist of platelet-derived growth factor. An analog ... Vasodilators, Phosphodiesterase inhibitors, Triazolopyrimidines, Diethylamino compounds, All stub articles, Cardiovascular ...
... (pyridylcarbinol) is a niacin derivative used as a hypolipidemic agent and as a vasodilator. It causes ... At least a couple of uses for this agent were discovered over the years: Eniclobrate Mepiroxol Nicofibrate Pantenicate ( ... Nicotinic acid is a brief peripheral vasodilator; this compound was made to make its action longer and effective. It provokes ... Topanicate, MG 28362) Norwood WF (1963). "Vasodilator Effects of Nicotinyl Tartrate (Roniacol Tartrate)". JAMA. 186: 1013. doi: ...
Medications used include: diuretic agents, vasodilator agents, positive inotropes, ACE inhibitors, beta blockers, and ... The inotropic agent dobutamine is advised only in the short-term use of acutely decompensated heart failure, and has no other ... The combination of isosorbide dinitrate/hydralazine is the only vasodilator regimen, other than ACE inhibitors or angiotensin ...
... quinazolinediones as possible peripheral vasodilators or antihypertensive agents". Journal of Medicinal Chemistry. 22 (12): ...
... as a vasodilator and antiplatelet agent. It is classified as a prostacyclin analog. It has been studied for the treatment of ...
"Shock and Hypotension in the Newborn Medication: Alpha/Beta Adrenergic Agonists, Vasodilators, Inotropic agents, Volume ... Inotropic agents, Motivation, Neurotransmitters, Norepinephrine-dopamine releasing agents, TAAR1 agonists, Biology of attention ... Some dopamine receptors are located in the walls of arteries, where they act as a vasodilator and an inhibitor of ... In blood vessels, it inhibits norepinephrine release and acts as a vasodilator (at normal concentrations); in the kidneys, it ...
The medications most likely to result in palpitations include sympathomimetic agents, anticholinergic drugs, vasodilators and ...
Representative agents include bromoform and dibromodimethylhydantoin ("DBDMH"). Some herbicides, such as bromoxynil, contain ... Commercially available organobromine pharmaceuticals include the vasodilator nicergoline, the sedative brotizolam, the ... Alkyl bromine compounds are often alkylating agents and the brominated aromatic derivatives are implicated as hormone ... alkyl bromides are alkylating agents. Carbon-halogen bond strengths, or bond dissociation energies are of 115, 83.7, 72.1, and ...
Like all halogens, it is thus one electron short of a full octet, and is hence a strong oxidising agent, reacting with many ... Commercially available organobromine pharmaceuticals include the vasodilator nicergoline, the sedative brotizolam, the ... It is also a weaker oxidising agent than chlorine, but a stronger one than iodine. Conversely, the bromide ion is a weaker ... A number of gaseous or highly volatile brominated halomethane compounds are non-toxic and make superior fire suppressant agents ...
The drug Brindley injected into his penis was a non-specific vasodilator, an alpha-blocking agent, and the mechanism of action ... The doctor may inject into the patient's bloodstream a contrast agent, which causes vascular tissues to stand out against other ... the injection of smooth-muscle relaxants and vasodilators directly into the penis, penile implants, the use of penis pumps, and ...
Commonly used agents include: Vasodilators acting as adenosine receptor agonists, such as adenosine itself, and dipyridamole ( ... Pharmacological stimulation from vasodilators such as dipyridamole or adenosine, or positive chronotropic agents such as ... Vasodilators are used to dilate coronary vessels, which causes increased blood velocity and flow rate in normal vessels and ... Pharmacologic agents such as adenosine, Lexiscan (regadenoson), or dipyridamole is generally used when a patient cannot achieve ...
Parenteral agents are classified into beta-blockers, calcium channel blockers, systemic vasodilators, or other (fenoldopam, ... Patients should have their blood pressure slowly lowered over a period of minutes to hours with an antihypertensive agent. ... Several classes of anti hypertensive agents are recommended, with the choice depending on the cause of the hypertensive crisis ... Hydralazine and Sodium nitroprusside are systemic vasodilators, thereby reducing afterload, however can be found to have reflex ...
In the latter condition, inhaled NO is used as a diagnostic test of the response of the pulmonary arteries to vasodilators ( ... Today, NO is not only used in breath tests but also as a therapeutic agent for conditions such as pulmonary arterial ... agents that relax the blood vessels). eNO has also been associated with wheeze, rhinitis and nasal allergy in primary school ...
... is a vasodilator agent affecting cardiovascular organs, such as heart, blood vessels and kidneys, with ...
Cyclandelate VP (nerve agent) Homosalate Bell, GD; Clegg, RJ; Ellis, WR; Middleton, B; White, DA (January 1984). "The effects ... 3,3,5-Trimethylcyclohexanol is a precursor to the vasodilator cyclandelate, the sunscreen component homosalate and the VP nerve ... Nerve agent precursors, All stub articles, Alcohol stubs). ... agent. It can be synthesized by hydrogenation of isophorone. It ...
"1-Subst-phenyl-2-amino-ethanols useful as beta adrenergic agents peripheral vasodilators and hypotensive agents" Staff (5 ... Suloctidil was a sulfur-containing aminoalcohol that was brought to market in the early 1970s as a vasodilator by Continental ...
... with the vasoactive pharmacological agents (vasoconstrictors or vasodilators and/or ACE Inhibitors and/or ARBs)(ACE = ... cardioactive or vasoactive agents. The measurement of CI and its derivatives allow clinicians to make timely patient assessment ... Pharmacological modulation of contractility is performed with cardioactive inotropic agents (positive or negative inotropes) ...
Inotropic agents, Vasodilators, Pyridazines, Phenol ethers, Dog medications). ... It is a calcium sensitizer and a selective inhibitor of phosphodiesterase 3 (PDE3) with positive inotropic and vasodilator ...
Inotropic agents, Vasodilators, Conjugated nitriles, 4-Pyridyl compounds, PDE3 inhibitors, 2-Pyridones). ... Milrinone, sold under the brand name Primacor, is a pulmonary vasodilator used in patients who have heart failure. It is a ... Shiao MJ, Shyu LM, Chen CF (1990). "Synthesis of Milrinone, a Cardiotonic Agent". Heterocycles. 31 (3): 523. doi:10.3987/COM-89 ...
Inotropic Agents, Vasodilators, Nitrates, B-type Natriuretic Peptides, I(f) Inhibitors, ARNIs, Diuretics, Loop, Diuretics, ... The goal in using these pharmacologic agents is to decrease the afterload so that the left ventricle is somewhat spared. The ... Medical therapy of chronic aortic regurgitation that is stable and asymptomatic involves the use of vasodilators. Trials have ...
Inotropic agents, 4-Pyridyl compounds, Vasodilators, PDE3 inhibitors, 2-Pyridones, Aromatic amines). ... Increases cardiac contractility, vasodilator. Acts by inhibiting the breakdown of both cAMP and cGMP by the phosphodiesterase ( ... as it functions as an arterial vasodilator and increases venous capacitance while decreasing venous return. There is a net ... "Relative Contribution of Inotropic and Vasodilator Effects of Amrinone- induced Hemodynamic improvement in congestive heart ...
Inotropic agents, Lactams, PDE3 inhibitors, Vasodilators). ... Quazinone (Dozonone) is a cardiotonic and vasodilator drug ... June 1985). "RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure". The ... Phosphodiesterase inhibitor David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN ... a novel positive inotropic agent with vasodilating properties". Journal of Cardiovascular Pharmacology. 6 (3): 511-9. doi: ...
Norepinephrine releasing agents, Stimulants, Sympathomimetics, Vasoconstrictors, Vasodilators, Heterocyclic compounds with 5 ... Whereas nitric oxide released in the corpus cavernosum is the major vasodilator contributing to the erectile process, ...
Vasodilators, All stub articles, Antihypertensive agent stubs, Dermatologic drug stubs). ... and is the active form of this agent. Minoxidil acts as a prodrug of minoxidil sulfate. Minoxidil sulfate is formed from ... Antihypertensive agents, Hair loss medications, Human drug metabolites, 1-Piperidinyl compounds, Potassium channel openers, ...
Pharmacology & pharmacy & pharmaceutical chemistry
It is a potent vasodilator agent, being a venous and arterial vasodilator, and it is used in patients with pulmonary ... Inotropic Agents. Class Summary. Inotropic agents such as milrinone, digoxin, dopamine, and dobutamine are used to increase the ... Vasodilators. Class Summary. In addition to diuretic therapy, vasodilators are recommended as first-line therapy for patients ... These agents are also indicated to reduce the risk of hospitalization for heart failure in patients with type 2 diabetes ...
Dipyridamole is also used in myocardial perfusion imaging, as an antiplatelet agent, and in combination with aspirin for stroke ... Dipyridamole, a non-nitrate coronary vasodilator that also inhibits platelet aggregation, is combined with other anticoagulant ...
If tachycardia is excessive, it may be necessary to use a beta-blocking agent concomitantly. Phenoxybenzamine is a long-acting ... adrenergic, alpha-receptor blocking agent which can produce and maintain "chemical sympathectomy" by oral administration. It ...
Vasodilator stress agents for myocardial perfusion imaging.. Rayan Saab, Fadi G Hage. Journal of Nuclear Cardiology 2017 April ... Importance: Only 1 class of glucose-lowering agents-. sodium-glucose cotransporter 2 (SGLT2) inhibitors-has. been reported to ...
Vasodilator Agents. Class Summary. The use of vasodilators to counteract vasoconstriction in IPAH is based on both theory and ... Positive Inotropic Agents. Class Summary. The use of an oral inotropic agent is advocated in patients with right ventricular ... Immunological Agents. Class Summary. It is important to consider immunization with palivizumab in infants and young children ... The effect of nifedipine does not appear to be specific to the pulmonary vasculature; this agent can cause systemic hypotension ...
... has role vasodilator agent (CHEBI:35620) nitric oxide (CHEBI:16480) is a inorganic radical (CHEBI: ... vasodilator agent A drug used to cause dilation of the blood vessels. ... bronchodilator agent An agent that causes an increase in the expansion of a bronchus or bronchial tubes. ... nitric oxide (CHEBI:16480) has role bronchodilator agent (CHEBI:35523) nitric oxide (CHEBI:16480) has role human metabolite ( ...
Rosendorff C (June 1993). "Beta-blocking agents with vasodilator activity". Journal of Hypertension Supplement. 11 (4): S37-40 ... Agents specifically labeled for migraine prophylaxis Timolol, propranolol Propranolol is the only agent indicated for the ... timolol Agents specifically labeled for cardiac arrhythmia Esmolol, sotalol, landiolol (Japan) Agents specifically labeled for ... depending on the concentration of the agent (beta blocker) and the concentration of the antagonized agent (usually an ...
Vasodilator Agents / therapeutic use Substances * Neuromuscular Agents * Vasodilator Agents * Botulinum Toxins, Type A ...
Vasodilator Agents * Iloprost ...
Agents Having Vasodilator Activity: Data on the effect of concomitant use of other vasodilators in patients receiving captopril ... Therefore, agents affecting sympathetic activity (e.g., ganglionic blocking agents or adrenergic neuron blocking agents) should ... additional antihypertensive agents (diuretics, beta blockers, centrally acting agents or vasodilators) were added as needed for ... Other antihypertensives such as diuretics, beta blockers, centrally acting agents or vasodilators may be used in conjunction ...
Because of the minimal amount of information on this potent agent, use minoxidil with caution, particularly when therapy ... Vasodilator Agents. Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. ... Because of the minimal amount of information on this potent agent, use minoxidil with caution, particularly when therapy ... Metabolism of minoxidil, a new hypotensive agent II: biotransformation following oral administration to rats, dogs, and monkeys ...
Vasodilator agent (HMDB: HMDB0003276). Physical Properties. State. Liquid. Experimental Molecular Properties. Property. Value. ... Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, ...
Other AHMs include selective aldosterone receptor inhibitors, peripheral vasodilators, alpha blockers, and centrally acting ... and centrally acting agents. ...
Nitric oxide is a powerful, naturally produced vasodilator used clinically as an inhaled agent. ... These agents competitively bind to endothelin-1 (ET-1) receptors ETA and ETB in endothelium and vascular smooth muscle, ... Pulmonary vasodilator therapy is associated with greater survival in Eisenmenger syndrome. Heart. 2017 Aug 9. 104:732-7. [QxMD ... These agents are useful to remove fluid and reduce preload and afterload in the treatment of heart failure. ...
Apelin is a novel vasodilator peptide and the most potent inotropic agent discovered to date. The apelin system is widely ...
Vasodilator Agents. *Vascular Resistance. *Surgery. *Pyridones. *Pulmonary Artery. *Nitric Oxide. *Monocrotaline. *Milrinone ...
A potent vasodilator agent that increases peripheral blood flow. ... A potent vasodilator agent that increases peripheral blood flow ...
Compare agents for hypertensive emergencies. View important safety information, ratings, user reviews, popularity and more. ... Generally, agents used in hypertensive emergencies are vasodilators, which widen blood vessels and reduce blood pressure. ... Agents for hypertensive emergencies. What are Agents for hypertensive emergencies?. Agents for hypertensive emergencies are ... List of Agents for hypertensive emergencies. View by Brand , Generic. Filter by All conditions. Heart Failure. Hypertensive ...
... and alpha-adrenergic blocking agents are both vasodilators with blood pressure-lowering effects. When vasodilators are used in ... and alpha-adrenergic blocking agents are both vasodilators with blood pressure-lowering effects. When vasodilators are used in ... Patients should be made aware that both alcohol and PDE5 inhibitors including STENDRA act as vasodilators. When vasodilators ... Both alcohol and PDE5 inhibitors, including STENDRA, act as vasodilators. When vasodilators are taken in combination, blood ...
... and alpha-adrenergic blocking agents are both vasodilators with blood-pressure-lowering effects. When vasodilators are used in ... Patients should be made aware that both alcohol and CIALIS, a PDE5 inhibitor, act as mild vasodilators. When mild vasodilators ... Both alcohol and CIALIS, a PDE5 inhibitor, act as mild vasodilators. When mild vasodilators are taken in combination, blood- ... Other Anti-Hypertensive Agents Amlodipine --A study was conducted to assess the interaction of amlodipine (5 mg daily) and ...
... an antiplatelet and vasodilator agent on gentamicin-induced nephrotoxicity in rats. ELSEVIER BV, 2001, 44, 321-328. 550 + 0. ...
... A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a ...
Co-administration with Other Vasodilators or Negative Chronotropic Agents: Use with caution due to additive pharmacodynamic ... In clinical trials where other vasodilators or negative chronotropic agents were co-administered with dexmedetomidine ... The intravenous administration of anticholinergic agents (e.g., glycopyrrolate, atropine) should be considered to modify vagal ... Nonetheless, caution should be used when such agents are administered concomitantly with dexmedetomidine hydrochloride. ...
Conventional treatments include cough and asthma drugs, expectorants, vasodilators, inotropic agents, and diuretics, which ...
Pharmacological Actions : Antihypertensive Agents, Antioxidants, Cardiovascular Agents, Cytoprotective, Vasodilator Agents. ... Pharmacological Actions : Anticholesteremic Agents, Antihypertensive Agents, Cardiovascular Agents, Hypoglycemic Agents. ... Pharmacological Actions : Anti-Inflammatory Agents, Antioxidants, Cardiovascular Agents, Neuroprotective Agents. Additional ... Pharmacological Actions : Anti-Fibrotic, Anti-Inflammatory Agents, Cardioprotective, Cardiovascular Agents, Hypoglycemic Agents ...
... is a technique of investigating the vasodilation of the peripheral microvasculature by delivering vasodilator agents across the ... eNOS is responsible for the generation of the vasodilator NO from l-arginine in the vascular endothelium(Reference Moncada and ... 3.Zeiher, AM (1996) Endothelial vasodilator dysfunction: Pathogenetic link to myocardial ischaemia or epiphenomenon. Lancet 348 ... This compound is used as an endothelium-independent vasodilator and acts as a control to test the integrity of vascular ...
1] Pharmacologic therapy includes anticoagulants, positive inotropic agents, and vasodilators.. Signs and symptoms. Infants and ... Children who respond to short-term vasodilator drug testing have a 5-year survival rate of 90%, whereas children who do not ... Before the age of vasodilator therapy, most children died within 1-2 years of diagnosis, whereas adults had a median survival ... Morbidity and mortality rates vary and depend on the age, the degree of pulmonary hypertension, and the response to vasodilator ...
A piperazine derivative, PHOSPHODIESTERASE 5 INHIBITOR and VASODILATOR AGENT that is used as a UROLOGICAL AGENT in the ...
The use of other vasodilators in angiotensin-converting enzyme inhibitor-intolerant patients was higher in the intervention ... Vasodilator Agents. *Treatment Outcome. *Survival Analysis. *Program Evaluation. *Pharmacists. *Patient Education as Topic ...
  • Pharmacologic therapy includes anticoagulants, positive inotropic agents, and vasodilators. (medscape.com)
  • Currently, no evidence shows the use of prostanoids or their analogues as pulmonary vasodilators and sole therapeutic agents for the treatment of PPHN in neonates (age 28 days or less). (cochrane.org)
  • Other pulmonary vasodilators are used during the perioperative period as well as for long-term treatment. (acc.org)
  • Epoprostenol (prostacyclin), a naturally occurring prostaglandin, is a potent vasodilator and inhibitor of platelet aggregation. (medscape.com)
  • Apelin is a novel vasodilator peptide and the most potent inotropic agent discovered to date. (ed.ac.uk)
  • A potent vasodilator agent that increases peripheral blood flow. (curehunter.com)
  • Minoxidil A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (scitoys.com)
  • Both vasoconstrictor and vasodilator neurohormones are stimulated and provide new therapeutic opportunities. (duke.edu)
  • These agents are useful to remove fluid and reduce preload and afterload in the treatment of heart failure. (medscape.com)
  • Clonidine hydrochloride USP tablets may be employed alone or concomitantly with other antihypertensive agents. (prescriptiondrugs.com)
  • With the advent of antihypertensive agents, the incidence of hypertensive emergencies in the United States has declined from 7% to approximately 1% of patients with hypertension. (medscape.com)
  • Details of antihypertensive drug therapy and compliance, intake of over-the-counter (OTC) preparations such as sympathomimetic agents, and use of illicit drugs such as cocaine are important elements of the medication history. (medscape.com)
  • The use of an oral inotropic agent is advocated in patients with right ventricular dysfunction that is associated with IPAH. (medscape.com)
  • Dipyridamole, a non-nitrate coronary vasodilator that also inhibits platelet aggregation, is combined with other anticoagulant drugs, such as warfarin, to prevent thrombosis in patients with valvular or vascular disorders. (pharmacycode.com)
  • An agent that causes an increase in the expansion of a bronchus or bronchial tubes. (ebi.ac.uk)
  • The positive inotropic and negative chronotropic effects of these agents are useful in the setting of left or right heart failure. (medscape.com)
  • These agents are also indicated to reduce the risk of hospitalization for heart failure in patients with type 2 diabetes mellitus who with either established cardiovascular disease or multiple cardiovascular risk factors. (medscape.com)
  • A piperazine derivative, PHOSPHODIESTERASE 5 INHIBITOR and VASODILATOR AGENT that is used as a UROLOGICAL AGENT in the treatment of ERECTILE DYSFUNCTION . (online-medical-dictionary.org)
  • Dipyridamole is also used in myocardial perfusion imaging, as an antiplatelet agent, and in combination with aspirin for stroke prophylaxis. (pharmacycode.com)
  • Vasodilator stress agents for myocardial perfusion imaging. (qxmd.com)
  • The use of vasodilators to counteract vasoconstriction in IPAH is based on both theory and on pathologic studies that implicate medial hypertrophy and vessel constriction in the pathogenesis of idiopathic pulmonary artery hypertension. (medscape.com)
  • If a pharmacologic stress test with a vasodilator such as adenosine or dipyridamole is to be performed, the patient should abstain from medications containing methylxanthines and beverages, food (such as chocolate), and medications containing caffeine for 12 h ( 2 ) to 24 h ( 3 , 4 ). (snmjournals.org)
  • Drugs reported to have triggered rosacea symptoms in some patients include topical steroids and oral vasodilators, ACE inhibitors and a cholesterol-lowering agent. (rosacea.org)
  • Epoprostenol is a strong vasodilator of all vascular beds. (medscape.com)
  • In both patients these lesions receded during the course of therapy with a selective arteriolar vasodilator, nifedipine.These observations are discussed in relation to the possible pathogenesis of the retinopathy seen in patientswith sickle cell anemia. (researchwithrutgers.com)
  • These agents competitively bind to endothelin-1 (ET-1) receptors ET A and ET B in endothelium and vascular smooth muscle, inhibiting vessel constriction and elevation of blood pressure. (medscape.com)
  • Maximal vasodilator capacity was examined by measuring minimal vascular resistance during peak reactive hyperemia after release from 10 minutes of arterial occlusion. (elsevierpure.com)
  • In the US, Minoxidil (minoxidil systemic) is a member of the drug class vasodilators and is used to treat High Blood Pressure . (drugs.com)
  • Clonidine hydrochloride USP is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0.1 mg, 0.2 mg and 0.3 mg. (prescriptiondrugs.com)
  • to test this approach in patients undergoing vasodilator stress tests with MDCT imaging in combination with the new vasodilator stress agent Regadenoson. (drugpatentwatch.com)
  • Particular features of these procedures include hemostasis of extended surfaces and wide-awake, conscious patients, and a combination of anesthetic agents and local vasoconstrictors is needed. (intechopen.com)
  • We examined maximal vasodilator capacity of forearm resistance vessels in 23 normotensive young men (mean blood pressure 94 ± 0.4 mm Hg, mean ± SE) with hypertensive relatives (age 24 ± 0.1 years) and in 17 normotensive subjects (mean blood pressure 85 ± 0.4 mm Hg) with no family history of hypertension (age 24 ± 0.1 years). (elsevierpure.com)
  • Vasodilator therapy has been an important advance: combination hydralazine and nitrate therapy was initially shown to be efficacious in improving survival, and more recently, angiotensin-converting enzyme (ACE) inhibitors, in the form of enalapril, have shown incremental benefit on survival over this combination. (duke.edu)
  • Agents for hypertensive emergencies are given parenterally as it is critical to reduce the blood pressure immediately because at that stage it could be life threatening. (drugs.com)
  • Generally, agents used in hypertensive emergencies are vasodilators, which widen blood vessels and reduce blood pressure. (drugs.com)
  • If tachycardia is excessive, it may be necessary to use a beta-blocking agent concomitantly. (pharmacycode.com)
  • When RV failure occurs following LVAD implantation, the mainstay of treatment is inotropic and pulmonary vasodilator support while volume status is optimized. (acc.org)
  • [2] The development of pharmacological agents (antibiotics, vasodilators, antioxidant, and Vitamins) has enhanced the healing of acute as well as chronic wounds. (esamskriti.com)
  • Phenoxybenzamine is a long-acting, adrenergic, alpha-receptor blocking agent which can produce and maintain "chemical sympathectomy" by oral administration. (pharmacycode.com)
  • Co-administration with Other Vasodilators or Negative Chronotropic Agents: Use with caution due to additive pharmacodynamic effects. (nih.gov)
  • Although, on balance, the weight of evidence concerning the long-term efficacy of inotropic agents has been disappointing, especially as it relates to their unfavorable effects on survival, recent information on vesnarinone, an agent with a complex and diversified mechanism of action, suggests that with appropriate doses, improved symptoms and survival are possible. (duke.edu)
  • We confirmed the previous findings that increasing metabolic vasodilator stimulus by performing intermittent handgrip exercise during 10 minutes of arterial occlusion did not augment peak dilation. (elsevierpure.com)
  • A combination of anesthetic agents and local vasoconstrictors is needed. (intechopen.com)
  • Caffeine and methylxanthines block the adenosine receptors on arterial smooth muscle cells, thus limiting the effectiveness of these vasodilator agents ( 4 ). (snmjournals.org)
  • In animal studies, captopril did not alter the pressor responses to a number of other agents, including angiotensin II and norepinephrine, indicating specificity of action. (nih.gov)
  • Amiodarone is a vasodilator which was found to be an effective anti-arrhythmic agent and is consequently in common usage. (radiopaedia.org)